Terms: = Germ cell tumor AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
60 results:
1. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
[TBL] [Abstract] [Full Text] [Related]
2. timp1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation.
Xu J; Wei C; Wang C; Li F; Wang Z; Xiong J; Zhou Y; Li S; Liu X; Yang G; Han L; Zhang J; Zhang S
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167041. PubMed ID: 38290591
[TBL] [Abstract] [Full Text] [Related]
3. Elevated Serum Gastrin Is Associated with Melanoma Progression: Putative Role in Increased Migration and Invasion of Melanoma cells.
Varga AJ; Nemeth IB; Kemeny L; Varga J; Tiszlavicz L; Kumar D; Dodd S; Simpson AWM; Buknicz T; Beynon R; Simpson D; Krenacs T; Dockray GJ; Varro A
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069171
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients.
Zhong Q; Zhong Q; Cai X; Wu R
Genes Genomics; 2023 Sep; 45(9):1211-1226. PubMed ID: 37301776
[TBL] [Abstract] [Full Text] [Related]
5. Machine learning modeling and prognostic value analysis of invasion-related genes in cutaneous melanoma.
Yang E; Ding Q; Fan X; Ye H; Xuan C; Zhao S; Ji Q; Yu W; Liu Y; Cao J; Fang M; Ding X
Comput Biol Med; 2023 Aug; 162():107089. PubMed ID: 37267825
[TBL] [Abstract] [Full Text] [Related]
6. An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma.
Tang G; Peng J; Huo L; Yin W
BMC Bioinformatics; 2023 Jun; 24(1):225. PubMed ID: 37264314
[TBL] [Abstract] [Full Text] [Related]
7. Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients.
Yu H; Wang M; Wang X; Jiang X
FEBS Open Bio; 2023 Feb; 13(2):307-322. PubMed ID: 36560848
[TBL] [Abstract] [Full Text] [Related]
8. An integrative bioinformatics investigation and experimental validation of critically involved genes in high-grade gliomas.
Ahmadi-Beni R; Shahbazi S; Khoshnevisan A
Diagn Pathol; 2022 Sep; 17(1):73. PubMed ID: 36153549
[TBL] [Abstract] [Full Text] [Related]
9. High levels of timp1 are associated with increased extracellular matrix stiffness in isocitrate dehydrogenase 1-wild type gliomas.
Luo CH; Shi Y; Liu YQ; Liu Q; Mao M; Luo M; Yang KD; Wang WY; Chen C; Niu Q; Yan ZX; Miao JY; Zhang XN; Zeng H; Li L; Bian XW; Ping YF
Lab Invest; 2022 Dec; 102(12):1304-1313. PubMed ID: 35882906
[TBL] [Abstract] [Full Text] [Related]
10. Identification of FABP7 as a Potential Biomarker for Predicting prognosis and Antiangiogenic Drug Efficacy of Glioma.
Hou L; Zhou H; Wang Y; Liu J; Zhang D; Li Y; Xue X
Dis Markers; 2022; 2022():2091791. PubMed ID: 35783014
[TBL] [Abstract] [Full Text] [Related]
11. Identification of Autophagy-Related Prognostic Signature and Analysis of Immune cell Infiltration in Low-Grade Gliomas.
Quan Q; Xiong X; Wu S; Yu M
Biomed Res Int; 2021; 2021():7918693. PubMed ID: 34790823
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive analysis of expression, prognosis and immune infiltration for timps in glioblastoma.
Han J; Jing Y; Han F; Sun P
BMC Neurol; 2021 Nov; 21(1):447. PubMed ID: 34781885
[TBL] [Abstract] [Full Text] [Related]
13. Ensemble based machine learning approach for prediction of glioma and multi-grade classification.
Chandra Joshi R; Mishra R; Gandhi P; Pathak VK; Burget R; Dutta MK
Comput Biol Med; 2021 Oct; 137():104829. PubMed ID: 34508971
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of microRNA-939-5p Contributes to cell Proliferation and Associates Poor prognosis in Glioma.
Zheng H; Zhao H; Ye G
Neuromolecular Med; 2021 Dec; 23(4):531-539. PubMed ID: 33786745
[TBL] [Abstract] [Full Text] [Related]
15. Identification of Hub Genes of Mesio Temporal Lobe Epilepsy and Prognostic Biomarkers of Brain Low-grade Gliomas Based on Bioinformatics Analysis.
Xu J; Sun M; Wang Y; Xie A; Gao J
Cell Transplant; 2020; 29():963689720978722. PubMed ID: 33327771
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine tumors.
Jiang S; Zhao L; Xie C; Su H; Yan Y
Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
[No Abstract] [Full Text] [Related]
17. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B
Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324
[TBL] [Abstract] [Full Text] [Related]
18. Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence.
Zhou W; Yu X; Sun S; Zhang X; Yang W; Zhang J; Zhang X; Jiang Z
Biomed Pharmacother; 2019 Oct; 118():109369. PubMed ID: 31545229
[TBL] [Abstract] [Full Text] [Related]
19. Co-expression of timp-1 and its cell surface binding partner CD63 in glioblastomas.
Aaberg-Jessen C; Sørensen MD; Matos ALSA; Moreira JM; Brünner N; Knudsen A; Kristensen BW
BMC Cancer; 2018 Mar; 18(1):270. PubMed ID: 29523123
[TBL] [Abstract] [Full Text] [Related]
20. Overexpression of timp-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma cell Lines.
Aaberg-Jessen C; Fogh L; Sørensen MD; Halle B; Brünner N; Kristensen BW
Pathol Oncol Res; 2019 Jan; 25(1):59-69. PubMed ID: 28963609
[TBL] [Abstract] [Full Text] [Related]
[Next]
